Chemical-induced cardiac reprogramming in vivo
文献类型:期刊论文
作者 | Huang, Chenwen4; Tu, Wanzhi1,3; Fu, Yanbin4; Wang, Jinxi2; Xie, Xin1,3,4,5![]() |
刊名 | CELL RESEARCH
![]() |
出版日期 | 2018-06 |
卷号 | 28期号:6页码:686-689 |
ISSN号 | 1001-0602 |
DOI | 10.1038/s41422018-0036-4 |
文献子类 | Letter |
WOS关键词 | CARDIOMYOCYTES ; FIBROBLASTS ; REGENERATION ; RATS |
资助项目 | Ministry of Science and Technology of China[2015CB964503] ; Ministry of Science and Technology of China[2017YFA0104002] ; Chinese Academy of Sciences[XDA16010202] ; Chinese Academy of Sciences[XDA16010201] ; National Natural Science Foundation of China[81425024] ; National Natural Science Foundation of China[81472862] ; National Natural Science Foundation of China[31501189] |
WOS研究方向 | Cell Biology |
语种 | 英语 |
CSCD记录号 | CSCD:6266445 |
WOS记录号 | WOS:000434816300010 |
出版者 | INST BIOCHEMISTRY & CELL BIOLOGY |
源URL | [http://119.78.100.183/handle/2S10ELR8/279730] ![]() |
专题 | 国家新药筛选中心 |
通讯作者 | Xie, Xin |
作者单位 | 1.Chinese Acad Sci, CAS Key Lab Receptor Res, Natl Ctr Drug Screening, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China; 2.Shanghai Jiao Tong Univ, Chinese Acad Sci, Sch Med, Key Lab Stem Cell Biol,Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; 3.ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China; 4.Tongji Univ, Shanghai Key Lab Signaling & Dis Res, Lab Receptor Based Biomed, Sch Life Sci & Technol, Shanghai 200092, Peoples R China; 5.Chinese Acad Sci, Shanghai Inst Mat Med, Natl Ctr Drug Screening, Stake Key Lab Drug Res, Shanghai 201203, Peoples R China |
推荐引用方式 GB/T 7714 | Huang, Chenwen,Tu, Wanzhi,Fu, Yanbin,et al. Chemical-induced cardiac reprogramming in vivo[J]. CELL RESEARCH,2018,28(6):686-689. |
APA | Huang, Chenwen,Tu, Wanzhi,Fu, Yanbin,Wang, Jinxi,&Xie, Xin.(2018).Chemical-induced cardiac reprogramming in vivo.CELL RESEARCH,28(6),686-689. |
MLA | Huang, Chenwen,et al."Chemical-induced cardiac reprogramming in vivo".CELL RESEARCH 28.6(2018):686-689. |
入库方式: OAI收割
来源:上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。